Up-to-date news about Intravacc

Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.

Category icon

Enabling Tech Transfer of B. pertussis OMV Technology to our Partner Chonquing Zhifei Biological Products

press 17Category icon

CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccinee

Category icon

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3

ShigelloisCategory icon

Intravacc announces the publication of a GMP process for a semi-synthetic Shigella glycoconjugate vaccine candidate from the Institut Pasteur

Contact us

You can send us an email:

Reach out to Business Development:

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!


Contact form

Subscribe to our newsletter